Creates a global coatings leader with $17 billion in revenue and an enterprise value of $25 billionSignificant value creation with approximately $600 million in cost synergies supporting strategic and ...

An announcement from Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh ( ($AU:RMD) ) is now available. ResMed Inc has ...

Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh ( ($AU:RMD) ) has provided an announcement. ResMed Inc. has reported ...

Adjusted EBITDA* was $8.0 million (8.8% of revenue) in FY25, compared to $12.0 million in FY24 (17.5% of revenue). CTW maintained positive Adjusted EBITDA while actively supporting new game launches ...

The stock options have an exercise price equal to $1.19 per share, the closing price of TELA Bio's common stock as reported on the Nasdaq Global Market on the Grant Date. The stock options have a ...

Increased ARR Leads to Higher Revenue and EBITDA Q3 2025 revenue grew modestly to $5.7M compared to $5.6M in Q2 2025 and Q3 2024 Q3 Adjusted EBITDA increased 71% to $933,000 compared to $546,000 in Q3 ...

Twin Hospitality faces pressure as FAT Brands moves to sell its 95% stake, raising risks for low-volume trading. Learn more ...

Adriana Kugler’s abrupt Fed exit hid major ethics breaches and denied waivers, exposing gaps in the central bank’s safeguards ...

Stocks finished mixed last week, with only the tech-heavy Nasdaq finishing lower by 0.45%. The S&P 500 and Dow Jones ...

Hologic ( (HOLX)) has provided an update. On November 4, 2025, Hologic, Inc.’s Compensation Committee approved a revised form of Restricted Stock Unit Award Agreement, indicating a strategic update in ...

CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit ...

Q3 2025 Earnings Call November 13, 2025 4:30 PM ESTCompany ParticipantsGregory Demopulos - Co-Founder, Chairman, CEO ...